Allucent is a global provider of drug development solutions for small and mid-sized biotech companies. The company offers a comprehensive suite of services including consulting, clinical operations, biometrics, and clinical pharmacology. With offices across North America, Europe, and the Middle East, Allucent has experience conducting trials in more than 60 countries, focusing on some of the most complex development areas including oncology, rare and orphan indications, and cell and gene therapies. Working with Water Street, Allucent has invested in deepening its oncology and regulatory expertise, bolstering its suite of solutions, and broadening its global network.

Subscribe to Water Street News

To receive Water Street news via email,
please complete the form below.

Privacy Policy

You’ve just been sent an email to confirm your email address. Please click on the link in the email to activate your subscription.

If you do not receive an email from us within a few minutes, please check your spam folder. If our email did not come through to you, please click on this link,

Something went wrong. If you are seeing this error, please let us know, and we will get it fixed asap.